Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.1394
-0.0154 (-9.95%)
Jul 22, 2026, 2:24 PM EDT - Market open
GOSS's stock price has decreased by -91.83% in the past year and price targets may not have had time to catch up.
Gossamer Bio Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $5 → $2 | Buy | Reiterates | $5 → $2 | +1,334.72% | Jun 25, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 19, 2026 |
| Wedbush | Wedbush | Hold Maintains $1 | Hold | Maintains | $1 | +617.36% | May 19, 2026 |
| Barclays | Barclays | Sell Maintains $0.3 → $0.28 | Sell | Maintains | $0.3 → $0.28 | +100.86% | May 19, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Mar 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $15 | Buy | Maintains | $15 | +10,660.40% | Mar 18, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Downgrades $8 → $0.5 | Hold | Downgrades | $8 → $0.5 | +258.68% | Feb 25, 2026 |
| Leerink Partners | Leerink Partners | Hold Downgrades $6 | Hold | Downgrades | $6 | +4,204.16% | Feb 23, 2026 |